Inventor
Esther BREIJ
Inventor
NL
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07KPeptides26%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12NMicroorganisms or enzymes4%
PatentTitleYear
12,589,150Antibodies binding AXL202612,577,316Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies202612,448,459Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof202512,275,797Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof202512,247,080Anti-DR5 antibodies and methods of use thereof202511,512,137Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof202211,396,553Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GENMAB HOLDING B V (5)· patent assignee history
2022–2026Based in NL· patent location history
2025Patents assigned to GENMAB BV (1)· patent assignee history
2026Patents assigned to GENMAB AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENMAB HOLDING B V | 5 | 2022–2026 |
| GENMAB AS | 1 | 2026 |
| GENMAB BV | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 7 | 2022–2026 |